Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 5Recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 141Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Hematologic Neoplasms 65Leukemia 36Leukemia, Lymphocytic, Chronic, B-Cell 34Myelodysplastic Syndromes 24Recurrence 23Lymphoma 23Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Neoplasms 14Multiple Myeloma 9Motor Activity 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Neoplasm, Residual 8Lymphoma, Non-Hodgkin 8Lymphoma, Follicular 8Lymphoma, B-Cell 8Leukemia, B-Cell 8Lymphoma, Mantle-Cell 6Burkitt Lymphoma 6Myeloproliferative Disorders 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Plasma Cell 5Leukemia, Myeloid, Chronic-Phase 5Febrile Neutropenia 5Waldenstrom Macroglobulinemia 4Pain 4Neoplasm Metastasis 4Leukemia, Myelomonocytic, Chronic 4

Interventions

venetoclax 1Stem Cell Transplantation 1Kidney Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Renal Insufficiency, Chronic × Other hematologic neoplasm × Clear all
NCT07358195 2026-01-22

Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation

Massachusetts General Hospital

Phase EARLY_PHASE1 Not yet recruiting
3 enrolled
Other hematologic neoplasm

Hematologic Neoplasms, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡